10 Top Drugs Now or Soon With Generic Equivalents
Overall spending on traditional prescription drugs -- mostly pills used to treat common conditions such as high cholesterol and depression -- will decline 4% by the end of 2015, largely because of the availability of generic medications, according Express Scripts. Here are 10 of the top brand-name d
Cymbalta

Used for: Depression
Manufactured by: Lilly
Estimated annual sales: $4.7 billion
Generic: duloxetine
Generic launch date: December 2013
Lidoderm 5%

Used for: Skin conditions
Manufactured by: Endo
Estimated annual sales: $1.3 billion
Generic: lidocaine topical patch
Generic launch date: September 2013
Niaspan

Used for: High blood cholesterol
Manufactured by: AbbVie
Estimated annual sales: $1.2 billion
Generic: niacin, extended release
Generic launch date: September 2013
AcipHex

Used for: Ulcer disease
Manufactured by: Eisai
Estimated annual sales: $901 million
Generic: rabeprazole
Generic launch date: November 2013
Suboxone Sublingual Tablets

Used for: Pain
Manufactured by: Reckitt Benkiser
Estimated annual sales: $697 million
Generic: buprenorphine/naloxone
Generic launch date: February 2013
Nexium

Used for: Ulcer disease
Manufactured by: AstraZeneca
Estimated annual sales: $6.1 billion
Generic: esomeprazole
Generic launch date: May 2014
Copaxone 20 mg/mL

Used for: Mental/neurological disorders
Manufactured by: Teva
Estimated annual sales: $3.7 billion
Generic: glatiramer acetate
Generic launch date: May 2014
Diovan

Used for: High blood pressure/heart disease
Manufactured by: Novartis
Estimated annual sales $2.1 billion
Generic: valsartan
Generic launch date: Mid-2014
Renvela

Used for: Gastrointestinal disorders
Manufactured by: Genzyme
Estimated annual sales: $889 million
Generic: sevelamer carbonate
Generic launch date: March 2014
Lunesta

Used for: Sleep disorders
Manufactured by: Sunovion
Estimated annual sales: $852 million
Generic: eszopiclone
Generic launch date: April 2014